Breakthrough in Bio-Organic Chemistry: Boron-Assisted Synthesis Overcomes Solubility Barriers in Protein Production

New boron-based reaction allows for the synthesis of poorly soluble proteins, paving the way for advanced cancer treatments and immunotherapies.

By: AXL Media

Published: Mar 11, 2026, 6:47 AM EDT

Source: Information for this report was sourced from ETH Zurich

The Challenge of Protein Aggregation in Synthetic Chemistry

Modern medicine relies heavily on proteins that are notoriously difficult to work with due to their poor solubility. These include signaling proteins, hormones, and membrane-anchored receptors, which represent the targets for approximately 60% of current pharmaceutical ingredients. In a laboratory setting, these molecules often reach a critical concentration threshold where they clump together, or aggregate, rendered them biologically useless. Traditional synthetic methods, which utilize specialized robots to link protein fragments, require high concentrations of reagents to function, creating a paradox where the necessary concentration for the reaction inevitably leads to the failure of the protein itself.

Accelerating Reaction Rates with Boron Catalysis

To resolve this bottleneck, a research team led by Professor Jeffrey Bode at ETH Zurich introduced boron atoms into carbon-based molecules to create a new class of reagents. Unlike standard biochemical processes that rely on high-speed enzymes, laboratory-based carbon chemistry is relatively slow. The ETH team’s method is approximately 1,000 times faster than conventional approaches. This increased velocity allows the coupling reaction to take place at 1,000 times lower concentrations, successfully joining protein segments before they have the opportunity to aggregate. By moving beyond purely carbon-based systems, the researchers have entered a chemical realm that allows for the rapid assembly of large, challenging biological molecules.

Engineering Chemical Packaging for Stability

The primary obstacle to utilizing boron in automated protein synthesis was the element's sensitivity to the harsh acids used in laboratory robots. While the team identified the potential of boron-fluorine groups as early as 2012, these compounds lacked the stability required for standardized manufacturing. After years of experimentation, the breakthrough arrived through a "caging" strategy. The team developed a protective chemical package that grips the reactive boron group from three sides. This structural shield prevents acidic degradation during the production cycle while maintaining the compound's unique reactivity, making it compatible with existing automated synthesis platforms.